Michael J. Odrich serves as Executive at RTI Biologics, Inc., where they oversee executive responsibilities. Since joining the company, Michael J. Odrich has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 28, 2011 involved receiving (via award) 18,587 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 28, 2011 | RTIX | $0 | Award | 18,587 | $N/A | Discretionary |
Michael J. Odrich currently holds 18,587 shares of RTI Biologics, Inc. (RTIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Odrich has been a net neutral trader of RTIX stock. They have purchased $0 and sold $0 worth of shares.
Michael J. Odrich's most recent insider trade was on Feb 28, 2011, when they sold 18,587 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted